| Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic TA Chan, M Yarchoan, E Jaffee, C Swanton, SA Quezada, A Stenzinger, ... Annals of Oncology 30 (1), 44-56, 2019 | 2080 | 2019 |
| Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ... Nature biotechnology 31 (6), 539-544, 2013 | 1183 | 2013 |
| Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ... Annals of Oncology 31 (11), 1491-1505, 2020 | 918 | 2020 |
| Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ... Annals of Oncology 29, iv238-iv255, 2018 | 891 | 2018 |
| The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma … A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ... Journal of clinical oncology 30 (13), 1438-1446, 2012 | 707 | 2012 |
| SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ... Nature metabolism 3 (2), 149-165, 2021 | 491 | 2021 |
| Tumor mutational burden as a predictive biomarker in solid tumors D Sha, Z Jin, J Budczies, K Kluck, A Stenzinger, FA Sinicrope Cancer discovery 10 (12), 1808-1825, 2020 | 488 | 2020 |
| Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... Journal for immunotherapy of cancer 8 (1), 2020 | 395 | 2020 |
| Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 317 | 2021 |
| Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment P Schelb, S Kohl, JP Radtke, M Wiesenfarth, P Kickingereder, ... Radiology 293 (3), 607-617, 2019 | 283 | 2019 |
| Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach S Wienert, D Heim, K Saeger, A Stenzinger, M Beil, P Hufnagl, M Dietel, ... Scientific reports 2 (1), 503, 2012 | 283 | 2012 |
| The landscape of metastatic progression patterns across major human cancers J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ... Oncotarget 6 (1), 570, 2015 | 280 | 2015 |
| Accurate and efficient detection of gene fusions from RNA sequencing data S Uhrig, J Ellermann, T Walther, P Burkhardt, M Fröhlich, B Hutter, ... Genome research 31 (3), 448-460, 2021 | 259 | 2021 |
| Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ... British journal of cancer 109 (10), 2665-2674, 2013 | 258 | 2013 |
| BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ... Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012 | 251 | 2012 |
| Integrative genomic and transcriptomic analysis of leiomyosarcoma P Chudasama, SS Mughal, MA Sanders, D Hübschmann, I Chung, ... Nature communications 9 (1), 144, 2018 | 239 | 2018 |
| Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells N Ertych, A Stolz, A Stenzinger, W Weichert, S Kaulfuß, P Burfeind, ... Nature cell biology 16 (8), 779-791, 2014 | 222 | 2014 |
| NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter, M Fröhlich, ... Cancer discovery 8 (9), 1087-1095, 2018 | 219 | 2018 |
| CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ... Nature medicine 22 (3), 278-287, 2016 | 216 | 2016 |
| Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ A Vogel, J Bridgewater, J Edeline, RK Kelley, HJ Klümpen, D Malka, ... Annals of Oncology 34 (2), 127-140, 2023 | 215 | 2023 |
Wilko WeichertInstitute of Pathology, Technical University Munich (TUM)在 tum.de 的电子邮件经过验证
